// App-Quantinova.ai

: High Effectiveness and Safety of Anti-CD7 CAR T-Cell Therapy in Treating Relapsed or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia (T-ALL)

Researchers

Presenter

  • Junfang Yang

Principal Investigators

  • Xian Zhang

  • Ying Liu

  • Xiao Yang

  • Hui Wang

  • Lin Wang

  • Jianqiang Li

  • Peihua Lu

Medical Centers

  • Hebei Yanda Lu Daopei Hospital, Langfang, China

  • Beijing Lu Daopei Institute of Hematology, Beijing, China

  • Department of Oncology, Capital Medical University, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

  • Epidermal growth factor receptor

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

Outcome

  • N/A

Study Design

  • Safety

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved